Highlights
- 1
- 2Diabetes care · 2020
- 3
Publications
582 publications
Funding
12 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- PIIRGC-10-23-484: Eye and brain imaging biomarkers in depressionHamad Medical Corporation · 2024–2026IRGC-10-23-484
- PIAQUA: NAtural History of Diabetic Neuropathy Quantified Using CorneAl Confocal MicroscopyProcter & Gamble Company · 2025–2026P&G AQUA-IST 243091
- PIEarlier diagnosis of peripheral neuropathy using A simple sCreening Tool (ACT)Procter & Gamble Company · 2024–2026PGC 243091-01
Completed grants (9)
- PICorneal Confocal Microscopy: A rapid diagnostic and prognostic imaging biomarker for neurodegeneration in dementiaQatar National Research Fund · 2020–2024NPRP12S-0213-190080
- PICorneal confocal microscopy: An imaging biomarker for neurodegeneration, inflammation and endothelial cell abnormalities in metabolic diseaseQatar National Research Fund · 2023–2023UREP29-261-3-078
- PIA Novel Contactless ANFIS-EMG System for Diabetic Sensorimotor Polyneuropathy (DSPN)Qatar Foundation · 2022–2023NPRP12S-0227-190164
- PIA noninvasive monitor to predict hypoglycemia in diabetes patientsQatar National Research Fund · 2019–2022NPRP11S-0110-180247
- PINCE Amendment to Grant AgreementAutism Research Institute · 2019–2021ARI 204712-01
- PIDoes Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on The Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication RiskQatar National Research Fund · 2016–2020NPRP 8-315-3-065
- PISubcontract with HMC sponsored by MerckMerck & Co., Inc. · 2018–2020ContractSA 184513-01
- PIMultinational Collaborative Evaluation of Corneal Confocal Microscopy as a Surrogate Endpoint for the Identification and Prediction of Diabetic Neuropathy in Type 1 DiabetesNIDDK · 2014–2018 · via NIH RePORTERDP3DK104386-01
- PICorneal Confocal Microscopy: a non-invasive surrogate for diabetic neuropathyNIDDK · 2008–2014 · via NIH RePORTERR01DK077903-05
Available technologies
1 technologyView full WCM portfolio ↗
Media highlights
1 clip
- Could One Daily Pill Narrow The Diabetes Treatment Gap In The Global South?Al Jazeera · November 16, 2026
Mentoring
1 mentee
External relationships
Advisory/Scientific Board Member
Novo Nordisk Pharmaceuticals, Inc. · Sanofi S.A.
Other
Procter & Gamble Company